EDGAR Filing Documents for 0001193125-23-249957

Form SC TO-C - Written communication relating to an issuer or third party:

SEC Accession No. 0001193125-23-249957

Filing Date

2023-10-03

Accepted

2023-10-03 16:30:51

Documents

Group Members

YOSEMITE FALLS ACQUISITION CORP

Document Format Files

Seq	Description	Document	Type	Size
1	SC TO-C	d457617dsctoc.htm	SC TO-C	20292
2	EX-99.1	d457617dex991.htm	EX-99.1	19919
3	GRAPHIC	g457617dsp4.jpg	GRAPHIC	10137
4	GRAPHIC	g457617g1003054413067.jpg	GRAPHIC	3180
5	GRAPHIC	g457617g1003054413208.jpg	GRAPHIC	2823
	Complete submission text file	0001193125-23-249957.txt		64696

Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285

Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000

ELI LILLY & Co (Filed by) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: SC TO-C
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268

Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (317) 543-9957

POINT Biopharma Global Inc. (Subject) CIK: 0001811764 (see all company filings)

IRS No.: 850800493 | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-91575 | Film No.: 231304272
SIC: 2834 Pharmaceutical Preparations